FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4317215069> ?p ?o ?g. }

• W4317215069 endingPage "1201" @default.
• W4317215069 startingPage "1190" @default.
• W4317215069 abstract "Previous analyses on sex differences in case fatality rates at population-level data had limited adjustment for key patient clinical characteristics thought to be associated with coronavirus disease 2019 (COVID-19) outcomes. We aimed to estimate the risk of specific organ dysfunctions and mortality in women and men.This retrospective cross-sectional study included 17 hospitals within 5 European countries participating in the International Survey of Acute Coronavirus Syndromes COVID-19 (NCT05188612). Participants were individuals hospitalized with positive severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from March 2020 to February 2022. Risk-adjusted ratios (RRs) of in-hospital mortality, acute respiratory failure (ARF), acute heart failure (AHF), and acute kidney injury (AKI) were calculated for women vs. men. Estimates were evaluated by inverse probability weighting and logistic regression models. The overall care cohort included 4499 patients with COVID-19-associated hospitalizations. Of these, 1524 (33.9%) were admitted to intensive care unit (ICU), and 1117 (24.8%) died during hospitalization. Compared with men, women were less likely to be admitted to ICU [RR: 0.80; 95% confidence interval (CI): 0.71-0.91]. In general wards (GWs) and ICU cohorts, the adjusted women-to-men RRs for in-hospital mortality were of 1.13 (95% CI: 0.90-1.42) and 0.86 (95% CI: 0.70-1.05; pinteraction = 0.04). Development of AHF, AKI, and ARF was associated with increased mortality risk (odds ratios: 2.27, 95% CI: 1.73-2.98; 3.85, 95% CI: 3.21-4.63; and 3.95, 95% CI: 3.04-5.14, respectively). The adjusted RRs for AKI and ARF were comparable among women and men regardless of intensity of care. In contrast, female sex was associated with higher odds for AHF in GW, but not in ICU (RRs: 1.25; 95% CI: 0.94-1.67 vs. 0.83; 95% CI: 0.59-1.16, pinteraction = 0.04).Women in GW were at increased risk of AHF and in-hospital mortality for COVID-19 compared with men. For patients receiving ICU care, fatal complications including AHF and mortality appeared to be independent of sex. Equitable access to COVID-19 ICU care is needed to minimize the unfavourable outcome of women presenting with COVID-19-related complications." @default.
• W4317215069 created "2023-01-18" @default.
• W4317215069 creator A5002073736 @default.
• W4317215069 creator A5002289527 @default.
• W4317215069 creator A5004801541 @default.
• W4317215069 creator A5004820076 @default.
• W4317215069 creator A5006268808 @default.
• W4317215069 creator A5010868918 @default.
• W4317215069 creator A5011468924 @default.
• W4317215069 creator A5012339002 @default.
• W4317215069 creator A5017366194 @default.
• W4317215069 creator A5018268116 @default.
• W4317215069 creator A5022250374 @default.
• W4317215069 creator A5022465204 @default.
• W4317215069 creator A5023817653 @default.
• W4317215069 creator A5024483983 @default.
• W4317215069 creator A5026504610 @default.
• W4317215069 creator A5035756988 @default.
• W4317215069 creator A5038188038 @default.
• W4317215069 creator A5040193116 @default.
• W4317215069 creator A5043119514 @default.
• W4317215069 creator A5050663970 @default.
• W4317215069 creator A5054946204 @default.
• W4317215069 creator A5055881015 @default.
• W4317215069 creator A5059007137 @default.
• W4317215069 creator A5059500249 @default.
• W4317215069 creator A5060339257 @default.
• W4317215069 creator A5061191457 @default.
• W4317215069 creator A5068883635 @default.
• W4317215069 creator A5072052040 @default.
• W4317215069 creator A5081510830 @default.
• W4317215069 creator A5086176378 @default.
• W4317215069 creator A5089266175 @default.
• W4317215069 creator A5091005877 @default.
• W4317215069 date "2023-01-18" @default.
• W4317215069 modified "2023-10-18" @default.
• W4317215069 title "Sex differences and disparities in cardiovascular outcomes of COVID-19" @default.
• W4317215069 cites W1600041372 @default.
• W4317215069 cites W2082195805 @default.
• W4317215069 cites W2110818436 @default.
• W4317215069 cites W2115098571 @default.
• W4317215069 cites W2584665637 @default.
• W4317215069 cites W2900215153 @default.
• W4317215069 cites W3002108456 @default.
• W4317215069 cites W3008028633 @default.
• W4317215069 cites W3013231340 @default.
• W4317215069 cites W3022455098 @default.
• W4317215069 cites W3032058780 @default.
• W4317215069 cites W3034521516 @default.
• W4317215069 cites W3037239830 @default.
• W4317215069 cites W3045594789 @default.
• W4317215069 cites W3110738325 @default.
• W4317215069 cites W3111905760 @default.
• W4317215069 cites W3134566701 @default.
• W4317215069 cites W3137149656 @default.
• W4317215069 cites W3149274369 @default.
• W4317215069 cites W3170259192 @default.
• W4317215069 cites W3198934400 @default.
• W4317215069 cites W3201179010 @default.
• W4317215069 cites W4205183800 @default.
• W4317215069 cites W4239001479 @default.
• W4317215069 doi "https://doi.org/10.1093/cvr/cvad011" @default.
• W4317215069 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36651866" @default.
• W4317215069 hasPublicationYear "2023" @default.
• W4317215069 type Work @default.
• W4317215069 citedByCount "1" @default.
• W4317215069 countsByYear W43172150692023 @default.
• W4317215069 crossrefType "journal-article" @default.
• W4317215069 hasAuthorship W4317215069A5002073736 @default.
• W4317215069 hasAuthorship W4317215069A5002289527 @default.
• W4317215069 hasAuthorship W4317215069A5004801541 @default.
• W4317215069 hasAuthorship W4317215069A5004820076 @default.
• W4317215069 hasAuthorship W4317215069A5006268808 @default.
• W4317215069 hasAuthorship W4317215069A5010868918 @default.
• W4317215069 hasAuthorship W4317215069A5011468924 @default.
• W4317215069 hasAuthorship W4317215069A5012339002 @default.
• W4317215069 hasAuthorship W4317215069A5017366194 @default.
• W4317215069 hasAuthorship W4317215069A5018268116 @default.
• W4317215069 hasAuthorship W4317215069A5022250374 @default.
• W4317215069 hasAuthorship W4317215069A5022465204 @default.
• W4317215069 hasAuthorship W4317215069A5023817653 @default.
• W4317215069 hasAuthorship W4317215069A5024483983 @default.
• W4317215069 hasAuthorship W4317215069A5026504610 @default.
• W4317215069 hasAuthorship W4317215069A5035756988 @default.
• W4317215069 hasAuthorship W4317215069A5038188038 @default.
• W4317215069 hasAuthorship W4317215069A5040193116 @default.
• W4317215069 hasAuthorship W4317215069A5043119514 @default.
• W4317215069 hasAuthorship W4317215069A5050663970 @default.
• W4317215069 hasAuthorship W4317215069A5054946204 @default.
• W4317215069 hasAuthorship W4317215069A5055881015 @default.
• W4317215069 hasAuthorship W4317215069A5059007137 @default.
• W4317215069 hasAuthorship W4317215069A5059500249 @default.
• W4317215069 hasAuthorship W4317215069A5060339257 @default.
• W4317215069 hasAuthorship W4317215069A5061191457 @default.
• W4317215069 hasAuthorship W4317215069A5068883635 @default.
• W4317215069 hasAuthorship W4317215069A5072052040 @default.
• W4317215069 hasAuthorship W4317215069A5081510830 @default.
• W4317215069 hasAuthorship W4317215069A5086176378 @default.

• next